Search
IP501
go.drugbank.com/drugs/DB06450ExperimentalThe compound was developed by Indevus Pharmaceuticals.
Rimtuzalcap
go.drugbank.com/drugs/DB16733InvestigationalRimtuzalcap is a novel modulator of small-conductance calcium-activated potassium channels that is under investigation for the treatment of essential tremor.
2'-fluoro-5-ethylarabinosyluracil
go.drugbank.com/drugs/DB13030Investigational2'-fluoro-5-ethylarabinosyluracil (FAU) has been used in trials studying the treatment of Small Intestine Lymphoma, Stage IV Mantle Cell Lymphoma, Waldenström Macroglobulinemia, Splenic Marginal Zone Lymphoma
Detirelix
go.drugbank.com/drugs/DB19488ExperimentalDetirelix has a monoisotopic molecular weight of 1536.78 Da.
Terdecamycin
go.drugbank.com/drugs/DB19720ExperimentalTerdecamycin has a monoisotopic molecular weight of 585.31 Da.
Stallimycin
go.drugbank.com/drugs/DB20261ExperimentalStallimycin has a monoisotopic molecular weight of 481.22 Da.
Sornidipine
go.drugbank.com/drugs/DB21432ExperimentalSornidipine has a monoisotopic molecular weight of 460.15 Da.
Polvitolimod
go.drugbank.com/drugs/DB21548ExperimentalPolvitolimod has a monoisotopic molecular weight of 323.1 Da.
Talogreptide mesaroxetan
go.drugbank.com/drugs/DB21743ExperimentalTalogreptide mesaroxetan has a monoisotopic molecular weight of 1769.07 Da.
Fumoxicillin
go.drugbank.com/drugs/DB20545ExperimentalFumoxicillin has a monoisotopic molecular weight of 443.12 Da.